日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

資訊|論壇|病例

搜索

首頁(yè) 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問(wèn)診所 愛(ài)醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫(kù) 醫(yī)學(xué)會(huì)議

您所在的位置:首頁(yè) > 腫瘤科診療指南 > 2007AUA臨床局限性前列腺癌指南

2007AUA臨床局限性前列腺癌指南

2014-05-04 21:34 閱讀:1974 來(lái)源:愛(ài)愛(ài)醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] In December 1995, the American Urological Association (AUA) published the Report on theManagement of Clinically Localized Prostate Cancer.

    《2007AUA臨床局限性前列腺癌指南》內(nèi)容簡(jiǎn)介:

    In December 1995, the American Urological Association (AUA) published the Report on theManagement of Clinically Localized Prostate Cancer.1The document was the culmination of sixyears of work by 17 clinicians and scientists and required the evaluation of 12,501 scientificpublications with the detailed extraction of ***rmation from 165 papers that met the rigorouscriteria of the panel of experts (Appendix 1). The Panel noted that a lack of evidence precludedspecific recommendations for optimal treatment of an individual patient, which patients shouldbe offered all treatment options, and that patient preferences should guide decision making.

    《2007AUA臨床局限性前列腺癌指南》內(nèi)容預(yù)覽:

    Since 1995, approximately 2,600,000 men2in the United States have been diagnosed withprostate cancer, and nearly 375,000 men3, 4have lost their lives to this disease. In addition, theNational Cancer Institute4has spent $2.1 billion on prostate cancer research and as of November2005, approximately 28,111 scientific papers concerning prostate cancer have been published inpeer-reviewed medical journals (OVID Search, December 31, 1995 to October 23, 2005; keyword: prostatic neoplasms). At the same time, mortality rates from prostate cancer have beendeclining: 34,475 men died in 1995 compared with an estimated 30,350 in 2005.4Severalpivotal randomized clinical trials related to prostate cancer treatment have been completed,including a chemoprevention study,5along with studies demonstrating prolongation of life inmen with hormone-refractory metastatic disease6, 7and improved outcomes in men withnonmetastatic disease.8-35With the use of new and combined treatments, the frequency andvariety of complications have differed from those previously reported. Advances have beenmade in prostate cancer imaging, biopsy methodology, in understanding causative factors anddisease, in treatment-related quality of life and in predicting the behavior of individual tumorsusing risk strata.

    點(diǎn)擊下載***:《2007AUA臨床局限性前列腺癌指南》


分享到:
  版權(quán)聲明:

  本站所注明來(lái)源為"愛(ài)愛(ài)醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來(lái)源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved